Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19)

Semin Thromb Hemost. 2022 Feb;48(1):124-126. doi: 10.1055/s-0041-1735452. Epub 2021 Sep 24.

Authors

Federico Chiurazzi¹, Antonella Tufano², Maria Esposito¹, Francesco D'Agostino¹, Aniello Casoria², Filomena Capasso³, Giovanni Di Minno²

Affiliations

¹ Department of Hematology and Bone Marrow Transplantation, University of Naples "Federico II," Naples, Italy.
² Department of Clinical Medicine and Surgery, University of Naples "Federico II," Naples, Italy.
³ Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II," Naples, Italy.

PMID: 34560795
DOI: 10.1055/s-0041-1735452

No abstract available

Publication types

Case Reports

MeSH terms

Adult
COVID-19* / complications
Factor V / antagonists & inhibitors*
Female
Humans

Substances

Factor V